Longevity logo

Continuous Glucose Monitoring Market Trends & Summary (2025–2033)

How Advancing Diabetes Technology, Homecare Adoption, and Smart Wearables Are Driving the CGM Market Toward US$ 14.1 Billion by 2033

By Diya DeyPublished about a month ago 5 min read

The global Continuous Glucose Monitoring (CGM) Market is entering a phase of rapid transformation, driven by rising diabetes prevalence, growing consumer acceptance of digital health tools, and strong advancements in sensor technology. According to Renub Research, the CGM market—valued at US$ 6.82 billion in 2024—is projected to reach US$ 14.1 billion by 2033, registering a CAGR of 8.41% throughout 2024–2033.

This surge reflects the accelerating shift toward real-time, personalized, and proactive diabetes management around the world.

Today, CGM systems have evolved far beyond simple glucose monitors. They are fully integrated digital health ecosystems linking sensors, transmitters, smartphones, artificial intelligence, and automated insulin delivery platforms. Their rise marks a pivotal moment in modern healthcare, as more patients and providers embrace continuous, data-driven care.

Download Free Sample Report

Understanding Continuous Glucose Monitoring: A New Standard in Diabetes Care

Continuous Glucose Monitoring refers to a wearable digital health technology that tracks glucose levels 24 hours a day, unlike traditional finger-stick testing that provides only snapshots. A tiny sensor placed under the skin measures glucose in interstitial fluid and transmits this information to a receiver or smartphone. Users can view real-time readings, glucose trends, and automatic alerts for high or low levels.

CGM devices provide three critical benefits:

Continuous insight into how glucose shifts throughout the day

Behavioral feedback, showing how meals, exercise, stress, or medication impact glucose

Safety alerts, enabling immediate action during hypoglycemic or hyperglycemic episodes

Because of these advantages, CGM is becoming indispensable for people with Type 1 diabetes and insulin-dependent Type 2 diabetes. Hospitals and clinics also increasingly deploy CGM systems for critically ill patients who require precise glucose management.

⭐ Key Growth Drivers in the CGM Market

1. Growing Global Diabetes Burden

The most significant driver of CGM adoption is the escalating global diabetes crisis.

Today:

537 million adults aged 20–79 live with diabetes

This number is expected to reach 643 million by 2030 and 783 million by 2045

Diabetes prevalence among adults nearly doubled, rising from 7% in 1990 to 14% in 2022

More concerningly, 59% of adults aged 30+ with diabetes did not take medication in 2022, underscoring widespread management gaps. CGM provides a much-needed, user-friendly approach to monitoring—helping patients better control their glucose levels and avoid life-threatening complications.

2. Breakthrough Innovations in CGM Technology

Technological advancements have dramatically improved device usability and performance:

Longer sensor wear times

More accurate readings without calibration

Smartphone and smartwatch connectivity

Integration with insulin pumps for automated insulin delivery

Predictive alerts powered by analytics and AI

A major industry milestone occurred in August 2024, when Abbott partnered with Medtronic to integrate Abbott’s FreeStyle Libre CGM with Medtronic’s automated insulin systems—signaling a new wave of cross-industry interoperability and enhanced patient convenience.

3. Rapid Homecare Expansion and Remote Patient Monitoring

The global healthcare industry is pivoting toward home-based care, largely due to increasing chronic diseases, aging populations, and rising hospital costs. CGM devices perfectly align with this shift:

They eliminate the need for frequent clinic visits

They allow cloud-based, remote monitoring

They support personalized therapy adjustments

CGM adoption is especially strong among pediatric and geriatric patients who require constant glucose visibility but benefit from seamless, wearable devices.

⚠️ Challenges Hindering CGM Market Growth

1. High Device Costs Limit Accessibility

Despite their benefits, CGM systems remain expensive. High upfront costs and recurring expenses for sensors and accessories create barriers in low- and middle-income countries, where insurance coverage is limited. This affordability gap continues to restrict market penetration.

2. Occasional Accuracy and Calibration Issues

While accuracy has greatly improved, discrepancies between blood glucose and interstitial readings still occur. Some models require periodic calibration, which affects user confidence. Closing this accuracy gap is essential to long-term adoption, especially in clinical settings.

🔍 Market by Component

✔ Sensors (The Heart of CGM Systems)

CGM sensors continuously track glucose levels and remain the largest revenue-generating segment. Today’s focus is on:

Longer wear time

Greater comfort

Reduced calibration

Cost-effective designs

Manufacturers are investing heavily in R&D to create next-generation sensors suitable for both homecare and hospital use.

✔ Receivers

Receivers display real-time glucose readings and allow data storage and trend analysis. The integration of receiver functions into smartphones, cloud dashboards, and wearables has strengthened this segment by enhancing patient engagement.

✔ Transmitters

Transmitters send data from sensors to monitoring devices. Although often overshadowed by sensors, they are crucial to seamless connectivity and play a vital role in device ecosystem interoperability.

🏥 Market by End User

Hospitals

CGM use in hospitals is expanding due to its ability to:

Reduce glycemic variability

Improve outcomes for critically ill patients

Aid perioperative glucose control

ICUs and surgical departments increasingly rely on CGM to prevent dangerous glucose fluctuations.

Homecare Settings

This is the fastest-growing segment, driven by:

Increased patient awareness

Digital health adoption

At-home diabetes management programs

Remote data sharing with clinicians

Homecare CGM adoption will continue rising, especially across aging populations and busy working professionals.

Others

This includes clinics, specialty centers, and wellness programs incorporating blood glucose tracking into broader metabolic monitoring.

🌍 Regional Market Outlook

🇺🇸 United States — The Global Leader in CGM Adoption

The U.S. dominates the CGM market due to:

High diabetes prevalence

Strong reimbursement policies

Advanced healthcare infrastructure

High digital health awareness

The CDC reports 98 million adults (37%) in the U.S. have prediabetes, most of whom are unaware. This has accelerated demand for accessible monitoring tools, making CGM a cornerstone of chronic disease prevention.

🇩🇪 Germany — Europe’s Most Advanced CGM Market

Germany’s robust adoption is supported by:

Insurance coverage for CGM devices

Strong patient education programs

Innovation-friendly regulatory systems

A January 2023 LifeScan-funded study published in the Journal of Diabetes Science and Technology analyzed over 144,000 individuals, reinforcing the importance of connected glucose monitoring technologies.

🇮🇳 India — A High-Growth Market Fueled by Massive Diabetes Burden

India’s CGM market is expanding quickly due to:

One of the world’s largest diabetic populations

Rising healthcare digitalization

Growing homecare adoption

In February 2023, Dario Health partnered with Dexcom to integrate Dexcom’s CGM data into Dario’s chronic care platform, improving real-time patient management.

🇧🇷 Brazil — Latin America’s Fastest-Emerging Market

Growth is driven by:

Increasing diabetes cases

Government support for advanced medical devices

Technological collaborations

In October 2023, Molex and GlucoModicum announced a needle-free, non-invasive CGM—an innovation expected to reshape the market.

🇦🇪 UAE — A Rising Hub for Digital Health Adoption

The UAE’s strong market performance reflects:

High prevalence of lifestyle diseases

Government investments in healthcare AI

A young, tech-savvy population

PureHealth’s AI-driven health app Pura surpassed 140,000 downloads in 2023, highlighting fast-growing consumer engagement with digital health platforms.

📊 Market Segmentation Overview

By Component

Sensors

Transmitters

Receivers

By End User

Hospitals

Homecare Settings

Others

By Geography

North America:

United States, Canada

Europe:

France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey

Asia Pacific:

China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand

Latin America:

Brazil, Mexico, Argentina

Middle East & Africa:

South Africa, Saudi Arabia, UAE

🏢 Key Companies Profiled

(Each assessed by overview, key personnel, recent developments, and revenue insights.)

Abbott Laboratories

Roche

Tandem Diabetes Care

DexCom Inc.

Senseonics Holdings Inc.

Ypsomed Holding AG

Medtronic Plc.

i-Sens Inc.

These companies are leading innovation through sensor miniaturization, AI-powered analytics, and fully automated insulin delivery ecosystems.

Final Thoughts: The Future of CGM Is Smarter, Smaller, and More Connected

The global CGM market is on a transformative path toward US$ 14.1 billion by 2033. As sensors become less invasive, algorithms more predictive, and digital tools more user-friendly, CGM is redefining diabetes care from reactive to proactive.

The next decade will see:

Wider affordability through low-cost sensors

Deep integration with wearable tech and smartwatches

AI-driven glucose prediction

Expanding adoption in developing countries

Full automation of insulin delivery systems

Ultimately, CGM technology is shifting the global healthcare system toward a future where chronic disease management is real-time, personalized, and much more effective.

fitnesshealthindustry

About the Creator

Diya Dey

Market Analyst

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.